A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children
Primary Purpose
Functional Constipation
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sodium phosphate enema
Normal saline enema
Mineral oil enema
Sponsored by
About this trial
This is an interventional treatment trial for Functional Constipation focused on measuring constipation, enema
Eligibility Criteria
Inclusion Criteria:
- Age 4-12 years
- Receiving enema in ED for presumed constipation
Exclusion Criteria:
- Critically ill patient
- Any history of renal insufficiency, renal disease, or elevated creatinine
- Any history of intestinal anatomic abnormality (i.e. anal stenosis, anal surgery, bowel obstruction, hirschprung's disease)
- An inability to self-report pain
- Presence of gastrostomy or jejunostomy tube
- Any history of gastrointestinal dysmotility
- Inability to read or speak English or Spanish
Sites / Locations
- Children's Hospital Los Angeles
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Experimental
Arm Label
Sodium phosphate enema
Normal saline enema
Mineral oil enema
Arm Description
Administration of sodium phosphate (fleets) enema for functional constipation in children ages 4-12 years Age 4-5: 33ml per rectum Age 5-12: 66ml per rectum
Administration of normal saline enema for functional constipation in children ages 4-12 years Admininstered as 10ml/kg with maximum of 700ml
Administration of mineral oil enema for functional constipation in children ages 4-12 years Administered as 66ml per rectum
Outcomes
Primary Outcome Measures
Change in pain scores following administration of enema
Secondary Outcome Measures
Full Information
NCT ID
NCT01823848
First Posted
March 26, 2013
Last Updated
January 29, 2019
Sponsor
Children's Hospital Los Angeles
1. Study Identification
Unique Protocol Identification Number
NCT01823848
Brief Title
A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children
Official Title
A Randomized Controlled Trial of Three Types of Enemas Used to Treat Functional Constipation in Children
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Terminated
Why Stopped
insufficient staff to enroll
Study Start Date
April 2013 (undefined)
Primary Completion Date
December 2017 (Actual)
Study Completion Date
December 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Children's Hospital Los Angeles
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Functional constipation is extremely common in children and is defined as painful, hard stools or firm stools for twice or less per week. Functional constipation accounts for 3% of general pediatric visits and up to 25% of pediatric gastroenterology visits. Constipation and fecal impaction can lead to a range of symptoms including decreased appetite, vomiting, and abdominal pain frequently resulting in Emergency Department (ED) presentation. In contrast to the outpatient setting where diet and oral medications work well to relieve symptoms related to functional constipation, ED management requires an approach with quicker results. For immediate relief of symptoms, disimpaction via enema use may be better than polyethylene glycol (PEG) 3350 for children. However, the type of enema to be used is not well studied. Currently, any patient presenting to the ED with a presumed diagnosis of abdominal pain due to functional constipation receives an oral dose of PEG and one of the following three types of enemas (based on the ED treating attending's discretion): phosphate or Fleets enema, normal saline enema, or mineral oil enema. There is no evidence in the literature that demonstrates any difference in the effectiveness of each of these enemas. The investigators propose a randomized control trial of the three types of pediatric enemas readily used in our ED to determine the best approach. There will be three arms within this study: a) PEG plus phosphate enema b) PEG plus normal saline enema and c) PEG plus mineral oil enema. The physicians enrolling patients will not be the treating physicians. The four principal investigators (blinded to the type of enema being used), following appropriate informed consent, will obtain pain scores (Faces Pain Scale - Revised) pre- and post-administration of each of the three treatments listed above in order to determine the best enema to use in children 4-12 years of age. Other outcomes to be analyzed will include the patient's weight pre- and post-administration of the enema, satisfaction ratings on a visual analog scale from the treating physician (who will also be blinded), and parental surveys on the day of administration and 3-5 days following discharge. Data analysis for pain scores will be completed with repeated measures anova. Categorical values will be compared using Chi Square analysis and continuous variables will be compared using parametric statistics.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Functional Constipation
Keywords
constipation, enema
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sodium phosphate enema
Arm Type
Active Comparator
Arm Description
Administration of sodium phosphate (fleets) enema for functional constipation in children ages 4-12 years Age 4-5: 33ml per rectum Age 5-12: 66ml per rectum
Arm Title
Normal saline enema
Arm Type
Active Comparator
Arm Description
Administration of normal saline enema for functional constipation in children ages 4-12 years Admininstered as 10ml/kg with maximum of 700ml
Arm Title
Mineral oil enema
Arm Type
Experimental
Arm Description
Administration of mineral oil enema for functional constipation in children ages 4-12 years Administered as 66ml per rectum
Intervention Type
Drug
Intervention Name(s)
Sodium phosphate enema
Other Intervention Name(s)
Fleets enema
Intervention Description
Rectally administered medication to treat constipation
Intervention Type
Drug
Intervention Name(s)
Normal saline enema
Intervention Description
Rectally administered medication to treat constipation
Intervention Type
Drug
Intervention Name(s)
Mineral oil enema
Intervention Description
Mineral oil enema administered to treat constipation. 66ml per rectum
Primary Outcome Measure Information:
Title
Change in pain scores following administration of enema
Time Frame
1-2 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age 4-12 years
Receiving enema in ED for presumed constipation
Exclusion Criteria:
Critically ill patient
Any history of renal insufficiency, renal disease, or elevated creatinine
Any history of intestinal anatomic abnormality (i.e. anal stenosis, anal surgery, bowel obstruction, hirschprung's disease)
An inability to self-report pain
Presence of gastrostomy or jejunostomy tube
Any history of gastrointestinal dysmotility
Inability to read or speak English or Spanish
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ara Festekjian, MD
Organizational Affiliation
CHLA Division of Emergency Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90027
Country
United States
12. IPD Sharing Statement
Learn more about this trial
A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children
We'll reach out to this number within 24 hrs